ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomega
May 05, 2017Vaccine was safe and elicited a potent immune response;Cytomegalovirus (CMV) infection is the leading cause of birth defects in the developed world, occurring in 1 – 2.5 % of all newborns and conferring risk of deafness and impaired intellectual developm
Pharma Sources Insight January 2025
